Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Sequenom Sells Bioscience Business to Agena

Published: Friday, May 30, 2014
Last Updated: Monday, June 02, 2014
Bookmark and Share
Sequenom, Inc completes the sale of its Bioscience business to Agena Bioscience, a portfolio company of Telegraph Hill Partners.

The terms of the agreement provide for a purchase price of $31.8 million, subject to certain adjustments, and Sequenom may also receive up to $4 million in contingent consideration upon the achievement of certain regulatory and sales milestones. Agena Bioscience also assumed certain liabilities related to the Bioscience business, which does not include any portion of Sequenom's bank debt or convertible notes outstanding. The facility lease for its Bioscience location in San Diego was also assumed by Agena Bioscience. All of the current Bioscience employees will be offered employment by Agena Bioscience. 

"We are pleased to sell the business to Agena Bioscience and Telegraph Hill Partners as they plan to invest in the growth of the Bioscience business to achieve its full potential. This sale strengthens our balance sheet, and will enable us to focus exclusively on our Sequenom Laboratories business as we work toward achieving profitability," said Harry F. Hixson, Jr., Chairman and CEO of Sequenom. 

The acquired business will continue to manufacture and sell the MassARRAY® System, a proprietary mass spectrometry-based genetic analysis instrument and associated products and services that provide research and clinical investigators with economical high multiplexing, high volume results, and precise quantification in a well-established platform technology. 

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,700+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Sequenom, Seoul National University Hospital Collaborate
Company expands clinical collaborations with leading cancer center in Asia.
Tuesday, October 06, 2015
Sequenom Announces Launch of SensiGene Fetal(XY) - Fetal Sex Determination Test
This is the company's second laboratory developed test powered by its SEQureDx™ technology.
Wednesday, February 17, 2010
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
Agreement covers extensive IP rights for AMD-related genetic variants that have been confirmed in multiple clinical studies around the world.
Wednesday, February 10, 2010
University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
New Study Uncovers Significant Proportion of Potential False Negatives in Widely Used HPV DNA Test which could lead to Cervical Cancer
Tuesday, July 14, 2009
SEQUENOM Announces Cost Cutting Initiative in Genetic Analysis Business
Company implements cost cutting initiatives to ensure the GA unit remains financially strong and approaches cash flow break-even.
Monday, April 27, 2009
Sequenom Selects PDI to Provide Sales Team for Launch of Noninvasive Prenatal Screening Tests
PDI to support the commercialization of SCMM's fetal Rhesus D genotyping test from a maternal blood sample.
Wednesday, March 04, 2009
Sequenom Announces Findings on Methylation Markers and RNA-SNP Markers
Company provides additional details on SEQureDx Trisomy 21 technology performance data.
Wednesday, February 04, 2009
Sequenom Announces Positive Data on Down Syndrome Detection and Unveils DNA Approach to Prenatal Diagnostics
Data continue to support market potential for Sequenom prenatal franchise; Down syndrome test on track for launch in June 2009.
Monday, February 02, 2009
Sequenom Announces Exclusive Licensing Agreement with Xenomics for Noninvasive Prenatal Diagnostics Using Transrenal DNA
Sequenom, Inc. announced that it has licensed from Xenomics, Inc. exclusive rights to patents (U.S. Patents 6,251,638 and RE 39,920, European Patent EP 0920539) for prenatal research and diagnostic products developed using fetal nucleic acids found in maternal urine.
Thursday, October 30, 2008
Sequenom Announces Licensing Agreement with Genomic Nanosystems
The license provides Sequenom with the exclusive right to use digital PCR methods for noninvasive prenatal diagnostics and analysis.
Tuesday, September 23, 2008
Sequenom Acquires License to Digital PCR and Other Noninvasive Prenatal Diagnostic Intellectual Property
The license expands Sequenom's IP portfolio of noninvasive prenatal diagnostic methods using fetal nucleic acids obtained from a maternal sample.
Wednesday, September 17, 2008
Sequenom Announces Results of Screening Studies for Down Syndrome
Company announces positive results from screening studies using the its noninvasive circulating cell-free fetal nucleic acid SEQureDx™ Technology.
Monday, June 09, 2008
Sequenom Announces Multiple MassARRAY Systems Sales in China
Beijing Genomics Institute which plans to use the MassARRAY system for its advanced research in viral genetics and human genetic projects.
Thursday, March 20, 2008
Sequenom Announces Multiple MassARRAY Systems Sales in China
Sequenom, Inc. has announced the sales of multiple MassARRAY(R) systems in China.
Wednesday, March 12, 2008
Sequenom Announces Key Milestone in Development of Noninvasive Prenatal Down Syndrome Test
Sequenom develops a noninvasive test for Trisomy 21, Down syndrome, that will incorporate multiple RNA fetal markers.
Thursday, February 21, 2008
Scientific News
Breaking Through the Barriers to Lab Innovation
Here we examine the drivers behind the move for greater innovation, the challenges and current trends in laboratory informatics, and the tools that can be used to break these barriers.
Education and Expense: The Barriers to Mass Spectrometry in Clinical Laboratories?
Here we examine the perceived barriers to mass spec in clinical laboratories and explore the possible drivers behind the recent shift in uptake of the technology in clinical settings.
Fruit Fly Pheromone Flags Great Real Estate for Starting a Family
Finding could aid efforts to control mosquito-borne diseases like malaria by manipulating odorants
Gene Editing Could Enable Pig-To-Human Organ Transplant
The largest number of simultaneous gene edits ever accomplished in the genome could help bridge the gap between organ transplant scarcity and the countless patients who need them.
Antioxidants Cause Malignant Melanoma to Metastasize Faster
Fresh research at Sahlgrenska Academy has found that antioxidants can double the rate of melanoma metastasis in mice.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Adult High Blood Pressure Risk Identifiable in Childhood
Groups of people at risk of having high blood pressure and other related health issues by age 38 can be identified in childhood, new University of Otago research suggests.
Analyzing Protein Structures in Their Native Environment
Enhanced-sensitivity NMR could reveal new clues to how proteins fold.
Supercoiled DNA is Far More Dynamic Than the “Watson-Crick” Double Helix
Researchers have imaged in unprecedented detail the three-dimensional structure of supercoiled DNA, revealing that its shape is much more dynamic than the well-known double helix.
Mini-kidneys Successfully Grown from Stem Cells
Researchers from Murdoch Childrens Research Institute have perfected a method of turning stem cells into mini-kidneys for use in drug screening, disease modelling and cell therapy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,700+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos